Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03310541
Title AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Advanced Solid Tumor

Therapies

Capivasertib

Capivasertib + Enzalutamide

Capivasertib + Fulvestrant

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST